The UNC School of Medicine faculty were prominently featured in various media outlets during the week of June 20-26, 2025. Several faculty members received recognition for their contributions to medical research and advancements.
Dr. Becky White was acknowledged with a Citation Award from the HIV Medical Association, as reported by both Women in Academia Report and The Journal of Blacks in Higher Education.
In cancer research, Dr. Jared Weiss’s work on palliative and curative radiation for lung cancer was highlighted by CURE magazine. Additionally, Dr. Lisa Carey from UNC’s Lineberger Cancer Center secured a $28 million grant for a new clinical trial, as covered by WCHL-FM.
Cardiovascular benefits of oral semaglutide were discussed by Dr. John Buse at the ADA 2025 conference, with Pharmacy Times reporting on the SOUL Trial findings. Dr. Buse’s insights into the CATALYST Trial and mifepristone’s role in improving glycemic control in type 2 diabetes patients with hypercortisolism were featured across multiple platforms including HCPLive, Healio, and MedPage Today.
Dr. Hanna K. Sanoff provided expert commentary on FDA restrictions concerning pembrolizumab/nivolumab use in PD-L1-low gastric cancer cases, shared by Oncology-CancerNetwork.
Other notable mentions include Dr. Ashwin Somasundaram discussing the increasing prevalence of young individuals diagnosed with cancer in North Carolina on WRAL-TV, while Dr. David Wohl addressed concerns about ‘razor blade’ sore throat symptoms potentially linked to a new COVID variant on Everyday Health.
